Targeting MDM4 Splicing in Cancers

被引：21

作者：

Bardot, Boris ^{[1
]}

Toledo, Franck ^{[1
]}

机构：

[1] PSL Res Univ, Sorbonne Univ, UPMC Univ Paris 06,Inst Curie,Ctr Rech, CNRS UMR 3244,Genet Suppress Tumorale,Equipe Lab, 26 Rue Ulm, F-75248 Paris 05, France

来源：

GENES | 2017年 / 8卷 / 02期

关键词：

MDM4; MDM2; p53; alternative splicing; isoform; PRE-MESSENGER-RNA; THERAPEUTIC TARGET; P53; INHIBITION; BCL-X; DOMAIN; MICE; EXPRESSION; REVEALS; CELLS; GENE;

D O I：

10.3390/genes8020082

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

MDM4, an essential negative regulator of the P53 tumor suppressor, is frequently overexpressed in cancer cells that harbor a wild-type P53. By a mechanism based on alternative splicing, the MDM4 gene generates two mutually exclusive isoforms: MDM4-FL, which encodes the full-length MDM4 protein, and a shorter splice variant called MDM4-S. Previous results suggested that the MDM4-S isoform could be an important driver of tumor development. In this short review, we discuss a recent set of data indicating that MDM4-S is more likely a passenger isoform during tumorigenesis and that targeting MDM4 splicing to prevent MDM4-FL protein expression appears as a promising strategy to reactivate p53 in cancer cells. The benefits and risks associated with this strategy are also discussed.

引用

页数：6

共 52 条

[21] Identification of Evolutionarily Conserved Exons as Regulated Targets for the Splicing Activator Tra2β in Development [J].

Grellscheid, Sushma ;

Dalgliesh, Caroline ;

Storbeck, Markus ;

Best, Andrew ;

Liu, Yilei ;

Jakubik, Miriam ;

Mende, Ylva ;

Ehrmann, Ingrid ;

Curk, Tomaz ;

Rossbach, Kristina ;

Bourgeois, Cyril F. ;

Stevenin, James ;

Grellscheid, David ;

Jackson, Michael S. ;

Wirth, Brunhilde ;

Elliott, David J. .

PLOS GENETICS, 2011, 7 (12)

[22] Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4 [J].

Grier, JD ;

Xiong, SB ;

Elizondo-Fraire, AC ;

Parant, JM ;

Lozano, G .

MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (01) :192-198

[23] Semi-supervised Learning Predicts Approximately One Third of the Alternative Splicing Isoforms as Functional Proteins [J].

Hao, Yanqi ;

Colak, Recep ;

Teyra, Joan ;

Corbi-Verge, Carles ;

Ignatchenko, Alexander ;

Hahne, Hannes ;

Wilhelm, Mathias ;

Kuster, Bernhard ;

Braun, Pascal ;

Kaida, Daisuke ;

Kislinger, Thomas ;

Kim, Philip M. .

CELL REPORTS, 2015, 12 (02) :183-189

[24] The spliceosome is a therapeutic vulnerability in MYC-driven cancer [J].

Hsu, Tiffany Y. -T. ;

Simon, Lukas M. ;

Neill, Nicholas J. ;

Marcotte, Richard ;

Sayad, Azin ;

Bland, Christopher S. ;

Echeverria, Gloria V. ;

Sun, Tingting ;

Kurley, Sarah J. ;

Tyagi, Siddhartha ;

Karlin, Kristen L. ;

Dominguez-Vidana, Rocio ;

Hartman, Jessica D. ;

Renwick, Alexander ;

Scorsone, Kathleen ;

Bernardi, Ronald J. ;

Skinner, Samuel O. ;

Jain, Antrix ;

Orellana, Mayra ;

Lagisetti, Chandraiah ;

Golding, Ido ;

Jung, Sung Y. ;

Neilson, Joel R. ;

Zhang, Xiang H-F. ;

Cooper, Thomas A. ;

Webb, Thomas R. ;

Neel, Benjamin G. ;

Shaw, Chad A. ;

Westbrook, Thomas F. .

NATURE, 2015, 525 (7569) :384-+

[25]

Jung J., 2016, NAT COMMUN, DOI [10.1038/ncomms1260927576846, DOI 10.1038/NCOMMS1260927576846]

[26] MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis [J].

Koh, Cheryl M. ;

Bezzi, Marco ;

Low, Diana H. P. ;

Ang, Wei Xia ;

Teo, Shun Xie ;

Gay, Florence P. H. ;

Al-Haddawi, Muthafar ;

Tan, Soo Yong ;

Osato, Motomi ;

Sabo, Arianna ;

Amati, Bruno ;

Wee, Keng Boon ;

Guccione, Ernesto .

NATURE, 2015, 523 (7558) :96-+

[27] Inactivation of the p53 pathway in retinoblastoma [J].

Laurie, Nikia A. ;

Donovan, Stacy L. ;

Shih, Chie-Schin ;

Zhang, Jiakun ;

Mills, Nicholas ;

Fuller, Christine ;

Teunisse, Amina ;

Lam, Suzanne ;

Ramos, Yolande ;

Mohan, Adithi ;

Johnson, Dianna ;

Wilson, Matthew ;

Rodriguez-Galindo, Carlos ;

Quarto, Micaela ;

Francoz, Sarah ;

Mendrysa, Susan M. ;

Guy, R. Kiplin ;

Marine, Jean-Christophe ;

Jochemsen, Aart G. ;

Dyer, Michael A. .

NATURE, 2006, 444 (7115) :61-66

[28] Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer [J].

Lenos, Kristiaan ;

Grawenda, Anna M. ;

Lodder, Kirsten ;

Kuijjer, Marieke L. ;

Teunisse, Amina F. A. S. ;

Repapi, Emmanouela ;

Grochola, Lukasz F. ;

Bartel, Frank ;

Hogendoorn, Pancras C. W. ;

Wuerl, Peter ;

Taubert, Helge ;

Cleton-Jansen, Anne-Marie ;

Bond, Gareth L. ;

Jochemsen, Aart G. .

CANCER RESEARCH, 2012, 72 (16) :4074-4084

[29] Functions of MDMX in the Modulation of the p53-Response [J].

Lenos, Kristiaan ;

Jochemsen, Aart G. .

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,

[30] HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis [J].

Liang, Mei ;

Han, Xin ;

Vadhan-Raj, Saroj ;

Nguyen, Martin ;

Zhang, Yu H. ;

Fernandez, Michael ;

Drakos, Elias ;

Konoplev, Sergej N. ;

Yin, C. Cameron ;

Miranda, Roberto N. ;

McDonnell, Timothy J. ;

Medeiros, L. Jeffrey ;

Bueso-Ramos, Carlos E. .

MODERN PATHOLOGY, 2010, 23 (03) :381-391

← 1 2 3 4 5 6 →